ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
ENvue Medical's ebitda for the twelve months ending Jun 30, 2026 was -$25.30M. For fiscal 2025 it was -$21.99M. The highest annual figure on record is -$3.44M in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.99M | – |
| FY2024 | Dec 31, 2024 | -$3.58M | – |
| FY2023 | Dec 31, 2023 | -$3.44M | – |
| FY2022 | Dec 31, 2022 | -$5.01M | – |
| FY2021 | Dec 31, 2021 | -$5.68M | – |
| FY2020 | Dec 31, 2020 | -$4.72M | – |
| FY2019 | Dec 31, 2019 | -$5.15M | – |
| FY2018 | Dec 31, 2018 | -$4.30M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.26M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.49M | – |
| Q4 FY2025 | Dec 31, 2025 | -$14.56M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.99M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.61M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.83M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$970.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$702.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$670.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.01M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.05M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.71M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.51M | – |
| Q3 FY2021 | Sep 30, 2021 | -$868.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$991.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.31M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.54M | – |
| Q3 FY2020 | Sep 30, 2020 | -$803.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.47M | – |
| Q1 FY2020 | Mar 31, 2020 | -$906.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.24M | – |
| Q3 FY2019 | Sep 30, 2019 | -$792.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.36M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.33M | – |
| Q2 FY2018 | Jun 30, 2018 | -$824.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$788.00K | – |
See a number that looks wrong?